Phase I human safety testing of 18-methoxycoronaridine (18-MC) as a treatment for leishmaniasis.
Phase of Trial: Phase I
Latest Information Update: 26 Sep 2014
Price : $35 *
At a glance
- Drugs 18-methoxycoronaridine (Primary)
- Indications Leishmaniasis
- Focus Adverse reactions
- 26 Sep 2014 New trial record
- 23 Sep 2014 Interim results published in a Savant HWP media release.